Gene Therapy Trial Clinical Hold Will Be Topic Of FDA, NIH Meetings
Executive Summary
FDA's Biological Response Modifiers Advisory Committee and NIH's Recombinant DNA Advisory Committee will each discuss the latest adverse event to occur in a French gene transfer trial at upcoming meetings